• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

验证韩国癌症预防研究 II 生物库中的乳腺癌风险预测模型。

Validating Breast Cancer Risk Prediction Models in the Korean Cancer Prevention Study-II Biobank.

机构信息

Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.

Division of Breast Surgery, Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.

出版信息

Cancer Epidemiol Biomarkers Prev. 2020 Jun;29(6):1271-1277. doi: 10.1158/1055-9965.EPI-19-1478. Epub 2020 Apr 3.

DOI:10.1158/1055-9965.EPI-19-1478
PMID:32245787
Abstract

BACKGROUND

Risk prediction models may be useful for precision breast cancer screening. We aimed to evaluate the performance of breast cancer risk models developed in European-ancestry studies in a Korean population.

METHODS

We compared discrimination and calibration of three multivariable risk models in a cohort of 77,457 women from the Korean Cancer Prevention Study (KCPS)-II. The first incorporated U.S. breast cancer incidence and mortality rates, U.S. risk factor distributions, and RR estimates from European-ancestry studies. The second recalibrated the first by using Korean incidence and mortality rates and Korean risk factor distributions, while retaining the European-ancestry RR estimates. Finally, we derived a Korea-specific model incorporating the RR estimates from KCPS.

RESULTS

The U.S. European-ancestry breast cancer risk model was well calibrated among Korean women <50 years [expected/observed = 1.124 (0.989, 1.278)] but markedly overestimated the risk for those ≥50 years [E/O = 2.472 (2.005, 3.049)]. Recalibrating absolute risk estimates using Korean breast cancer rates and risk distributions markedly improved the calibration in women ≥50 [E/O = 1.018 (0.825, 1.255)]. The model incorporating Korean-based RRs had similar but not clearly improved performance relative to the recalibrated model.

CONCLUSIONS

The poor performance of the U.S. European-ancestry breast cancer risk model among older Korean women highlights the importance of tailoring absolute risk models to specific populations. Recalibrating the model using Korean incidence and mortality rates and risk factor distributions greatly improved performance.

IMPACT

The data will provide valuable information to plan and evaluate actions against breast cancer focused on primary prevention and early detection in Korean women.

摘要

背景

风险预测模型可能有助于精确的乳腺癌筛查。我们旨在评估在韩国人群中开发的欧洲裔研究乳腺癌风险模型的性能。

方法

我们比较了三种多变量风险模型在韩国癌症预防研究(KCPS)-II 队列中 77457 名女性中的区分度和校准度。第一个模型纳入了美国乳腺癌发病率和死亡率、美国风险因素分布以及欧洲裔研究的 RR 估计值。第二个模型通过使用韩国的发病率和死亡率以及韩国的风险因素分布重新校准了第一个模型,同时保留了欧洲裔的 RR 估计值。最后,我们得出了一个包含 KCPS 中 RR 估计值的韩国特定模型。

结果

美国欧洲裔乳腺癌风险模型在韩国<50 岁的女性中校准良好[预期/观察值=1.124(0.989,1.278)],但对≥50 岁的女性风险估计过高[E/O=2.472(2.005,3.049)]。使用韩国乳腺癌发病率和风险分布重新校准绝对风险估计值,显著改善了≥50 岁女性的校准[E/O=1.018(0.825,1.255)]。纳入基于韩国的 RR 的模型与重新校准的模型相比,表现相似但不明显改善。

结论

在美国年龄较大的韩国女性中,美国欧洲裔乳腺癌风险模型表现不佳,这突出了针对特定人群定制绝对风险模型的重要性。使用韩国的发病率和死亡率以及风险因素分布重新校准模型极大地提高了性能。

影响

这些数据将为韩国女性的乳腺癌一级预防和早期检测的规划和评估行动提供有价值的信息。

相似文献

1
Validating Breast Cancer Risk Prediction Models in the Korean Cancer Prevention Study-II Biobank.验证韩国癌症预防研究 II 生物库中的乳腺癌风险预测模型。
Cancer Epidemiol Biomarkers Prev. 2020 Jun;29(6):1271-1277. doi: 10.1158/1055-9965.EPI-19-1478. Epub 2020 Apr 3.
2
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
3
Prophylactic mastectomy for the prevention of breast cancer.预防性乳房切除术用于预防乳腺癌。
Cochrane Database Syst Rev. 2004 Oct 18(4):CD002748. doi: 10.1002/14651858.CD002748.pub2.
4
Oncoplastic breast-conserving surgery for women with primary breast cancer.原发性乳腺癌患者的肿瘤整形保乳手术。
Cochrane Database Syst Rev. 2021 Oct 29;10(10):CD013658. doi: 10.1002/14651858.CD013658.pub2.
5
Risk-reducing mastectomy for the prevention of primary breast cancer.预防性乳房切除术以预防原发性乳腺癌。
Cochrane Database Syst Rev. 2018 Apr 5;4(4):CD002748. doi: 10.1002/14651858.CD002748.pub4.
6
Long-term hormone therapy for perimenopausal and postmenopausal women.围绝经期和绝经后女性的长期激素治疗
Cochrane Database Syst Rev. 2017 Jan 17;1(1):CD004143. doi: 10.1002/14651858.CD004143.pub5.
7
Mammographic density, endocrine therapy and breast cancer risk: a prognostic and predictive biomarker review.乳腺密度、内分泌治疗与乳腺癌风险:预后和预测生物标志物综述。
Cochrane Database Syst Rev. 2021 Oct 26;10(10):CD013091. doi: 10.1002/14651858.CD013091.pub2.
8
Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men.降低男男性行为者中艾滋病毒性传播风险的行为干预措施。
Cochrane Database Syst Rev. 2008 Jul 16(3):CD001230. doi: 10.1002/14651858.CD001230.pub2.
9
Platinum-containing regimens for metastatic breast cancer.转移性乳腺癌的含铂方案。
Cochrane Database Syst Rev. 2017 Jun 23;6(6):CD003374. doi: 10.1002/14651858.CD003374.pub4.
10
Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations.对携带BRCA1或BRCA2基因突变的女性进行降低风险的双侧输卵管卵巢切除术。
Cochrane Database Syst Rev. 2018 Aug 24;8(8):CD012464. doi: 10.1002/14651858.CD012464.pub2.

引用本文的文献

1
Wasm-iCARE: a portable and privacy-preserving web module to build, validate, and apply absolute risk models.Wasm-iCARE:一个用于构建、验证和应用绝对风险模型的便携式且保护隐私的网络模块。
JAMIA Open. 2024 Jun 27;7(2):ooae055. doi: 10.1093/jamiaopen/ooae055. eCollection 2024 Jul.
2
Wasm-iCARE: a portable and privacy-preserving web module to build, validate, and apply absolute risk models.Wasm-iCARE:一个用于构建、验证和应用绝对风险模型的便携式且保护隐私的网络模块。
ArXiv. 2023 Oct 13:arXiv:2310.09252v1.
3
Development of a Breast Cancer Risk Prediction Model Incorporating Polygenic Risk Scores and Nongenetic Risk Factors for Korean Women.

本文引用的文献

1
iCARE: An R package to build, validate and apply absolute risk models.iCARE:用于构建、验证和应用绝对风险模型的 R 包。
PLoS One. 2020 Feb 5;15(2):e0228198. doi: 10.1371/journal.pone.0228198. eCollection 2020.
2
Comparative Validation of Breast Cancer Risk Prediction Models and Projections for Future Risk Stratification.比较乳腺癌风险预测模型的验证及对未来风险分层的预测。
J Natl Cancer Inst. 2020 Mar 1;112(3):278-285. doi: 10.1093/jnci/djz113.
3
Contrasting Epidemiology and Clinicopathology of Female Breast Cancer in Asians vs the US Population.
纳入多基因风险评分和非遗传风险因素的韩国女性乳腺癌风险预测模型的建立。
Cancer Epidemiol Biomarkers Prev. 2023 Sep 1;32(9):1182-1189. doi: 10.1158/1055-9965.EPI-23-0064.
4
Polygenic scoring accuracy varies across the genetic ancestry continuum.多基因评分准确性在遗传祖先连续体上有所差异。
Nature. 2023 Jun;618(7966):774-781. doi: 10.1038/s41586-023-06079-4. Epub 2023 May 17.
5
Breast Cancer Risk Assessment Tools for Stratifying Women into Risk Groups: A Systematic Review.用于将女性分层为风险组的乳腺癌风险评估工具:一项系统评价。
Cancers (Basel). 2023 Feb 9;15(4):1124. doi: 10.3390/cancers15041124.
6
Polygenic risk scores for prediction of breast cancer in Korean women.多基因风险评分在韩国女性乳腺癌预测中的应用。
Int J Epidemiol. 2023 Jun 6;52(3):796-805. doi: 10.1093/ije/dyac206.
7
Machine Learning Algorithms to Predict Recurrence within 10 Years after Breast Cancer Surgery: A Prospective Cohort Study.预测乳腺癌手术后10年内复发的机器学习算法:一项前瞻性队列研究。
Cancers (Basel). 2020 Dec 17;12(12):3817. doi: 10.3390/cancers12123817.
亚洲女性乳腺癌的流行病学和临床病理学与美国人群的对比。
J Natl Cancer Inst. 2019 Dec 1;111(12):1298-1306. doi: 10.1093/jnci/djz090.
4
Adult height in relation to risk of cancer in a cohort of 22,809,722 Korean adults.22809722 名韩国成年人队列中与癌症风险相关的成人身高。
Br J Cancer. 2019 Mar;120(6):668-674. doi: 10.1038/s41416-018-0371-8. Epub 2019 Feb 19.
5
Menopausal hormone therapy and breast cancer risk: effect modification by body mass through life.绝经后激素治疗与乳腺癌风险:通过终生体重对其的影响修饰作用。
Eur J Epidemiol. 2019 Mar;34(3):267-278. doi: 10.1007/s10654-018-0431-7. Epub 2018 Aug 6.
6
Updates on Cancer Epidemiology in Korea, 2018.2018年韩国癌症流行病学最新情况
Chonnam Med J. 2018 May;54(2):90-100. doi: 10.4068/cmj.2018.54.2.90. Epub 2018 May 25.
7
Cohort Profile: The Korean Cancer Prevention Study-II (KCPS-II) Biobank.队列简介:韩国癌症预防研究-II(KCPS-II)生物样本库
Int J Epidemiol. 2018 Apr 1;47(2):385-386f. doi: 10.1093/ije/dyx226.
8
Screening Mammography in Women 40-49 Years Old: Current Evidence.40-49 岁女性的乳房 X 光筛查:当前证据。
AJR Am J Roentgenol. 2018 Feb;210(2):264-270. doi: 10.2214/AJR.17.18707. Epub 2017 Oct 24.
9
Light Alcohol Drinking and Risk of Cancer: A Meta-Analysis of Cohort Studies.轻量饮酒与癌症风险:队列研究的荟萃分析。
Cancer Res Treat. 2018 Apr;50(2):474-487. doi: 10.4143/crt.2017.094. Epub 2017 May 22.
10
Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications.乳腺癌风险模型:现有模型的全面概述、验证及临床应用。
Breast Cancer Res Treat. 2017 Jul;164(2):263-284. doi: 10.1007/s10549-017-4247-z. Epub 2017 Apr 25.